The Food and Drug Administration identified 39 new drug and biological product shortages in 2017, up from 26 in 2016, and 41 ongoing shortages from prior years, according to the agency’s latest annual report on the issue. “Although the number of new drug shortages has declined since 2011 as a result of work by many groups including the FDA, shortages continue to pose a real challenge to public health,” the report states. “This is especially the case when a shortage involves a critical drug to treat cancer, to provide parenteral nutrition, or to address another serious medical condition, such as the shortage of intravenous saline solution. While there has been a steady decrease in new shortages over the past few years, 2017 has been a challenging year for shortages. First, there was a major manufacturer who shut down a facility for remediation purposes resulting in loss of manufacturing capacity needed for the supplies of numerous products. Critically, disruptions were also caused in the fall of 2017 by Hurricanes Harvey, Irma and Maria – the latter of which ravaged Puerto Rico, an island that is home to numerous manufacturing facilities.” The American Society of Health-System Pharmacists, AHA and other organizations last year convened a Drug Shortages Roundtable, which issued policy recommendations to minimize the impact of drug shortages on patient care.

Related News Articles

Headline
The AHA today submitted to the Food and Drug Administration legislative, regulatory and best practice recommendations to address new and chronic prescription…
Headline
The AHA, American Society of Anesthesiologists, American Society of Clinical Oncology, American Society of Health-System Pharmacists, and Institute for Safe…
Headline
The National Academies of Sciences, Engineering and Medicine has released a report summarizing its Sept. 5-6 workshop on medical drug shortages during…
Headline
The Food and Drug Administration will hold a public meeting Nov. 27 to receive stakeholder input on the underlying systemic causes of drug shortages and…
Headline
Several hospitals and health systems today officially established Civica Rx – a new not-for-profit generic drug company that will help patients by addressing…
Headline
The Drug Enforcement Administration today issued its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would…